Healthtech Solutions, Inc./UT financial data

Industry
Surgical & Medical Instruments & Apparatus
Location
181 Dante Avenue, Tuckahoe, NY
State of incorporation
UT
Fiscal year end
December 31
Former names
HYB Holding Corp. (to 12/8/2020), XINYINHAI TECHNOLOGY, LTD. (to 3/19/2020), IRON STAR DEVELOPMENT, INC. (to 10/12/2006)
Latest financial report
10-K - Q4 2022 - Jun 28, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 30.2 % -30.9%
Debt-to-equity -190 % +85.4%
Return On Equity 124 % -98.9%
Return On Assets -201 % +78.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 96.1M shares +43.6%
Common Stock, Shares, Outstanding 72.2M shares +7.84%
Entity Public Float 6.95M USD 0%
Common Stock, Value, Issued 72.2K USD +7.84%
Weighted Average Number of Shares Outstanding, Basic 67.3M shares +131%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 776K USD
Cost of Revenue 51.8K USD
Research and Development Expense 1.77M USD +1009%
General and Administrative Expense 2.84M USD +49.5%
Operating Income (Loss) -3.46M USD +30.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -845K USD +29.9%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -3.04M USD +66.6%
Earnings Per Share, Basic -0.01 USD/shares +75%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 97.6K USD +1274%
Accounts Receivable, after Allowance for Credit Loss, Current 1.24M USD
Inventory, Net 404K USD
Assets, Current 2.46M USD +687%
Property, Plant and Equipment, Net 83.3K USD
Assets 2.75M USD +551%
Liabilities, Current 5.83M USD +444%
Liabilities 5.83M USD +444%
Retained Earnings (Accumulated Deficit) -13.7M USD -29.7%
Stockholders' Equity Attributable to Parent -2.75M USD -325%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -3.07M USD -375%
Liabilities and Equity 2.75M USD +551%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -566K USD -150%
Net Cash Provided by (Used in) Financing Activities 658K USD +535%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 72.2M shares +7.84%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 97.6K USD +1274%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 3.6M USD +31.4%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 3.6M USD +31.4%
Lessee, Operating Lease, Liability, to be Paid 389K USD
Operating Lease, Liability, Current 375K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 389K USD
Additional Paid in Capital 10.9M USD +10.4%
Amortization of Intangible Assets 0 USD -100%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 0 USD -100%